Airway Therapeutics Announces FDA Acceptance of IND for AT-100...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
CINCINNATI, March 26, 2021 /PRNewswire-AsiaNet/ -- -- Initiating Phase 1b randomized clinical trial with initial results expected in late 2021-- Potential for novel, preventive AT-100 to reduce incidence and severity of serious respiratory disease BPD, improving outcomes and survival in very p...
Authors: LATEST ASIANET NEWS RELEASES